The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 26, 2021

Filed:

Mar. 11, 2021
Applicant:

Kashiv Specialty Pharmaceuticals, Llc, Bridgewater, NJ (US);

Inventors:

Siva Ram Kiran Vaka, Piscataway, NJ (US);

Paras Jariwala, Somerset, NJ (US);

Jaydeep Vaghashiya, Franklin park, NJ (US);

Atsawin Thongsukmak, Basking Ridge, NJ (US);

Dipen Desai, Whippany, NJ (US);

Wantanee Phuapradit, Montville, NJ (US);

Navnit H. Shah, Monmouth Junction, NJ (US);

Assignee:

AMNEAL COMPLEX PRODUCTS RESEARCH LLC, Bridgewater, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 31/138 (2006.01); A61K 31/155 (2006.01); A61K 31/165 (2006.01); A61K 31/4045 (2006.01); A61K 31/4178 (2006.01); A61K 31/4458 (2006.01); A61K 31/573 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01);
U.S. Cl.
CPC ...
A61K 9/0004 (2013.01); A61K 9/2027 (2013.01); A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61K 9/2086 (2013.01); A61K 31/138 (2013.01); A61K 31/155 (2013.01); A61K 31/165 (2013.01); A61K 31/4045 (2013.01); A61K 31/4178 (2013.01); A61K 31/4458 (2013.01); A61K 31/573 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01);
Abstract

The present disclosure provides programmable osmotic-controlled oral compositions providing delayed release of a therapeutically acceptable amount of a drug. The programmable osmotic-controlled compositions of the disclosure provide a lag time that is independent of the presence or absence of food, type of food, pH, gastric emptying, gastric motility, and volume and viscosity of gastric fluid. The compositions of the disclosure can be programmed to provide a desired and precise lag time, and release drug, after the lag time, at a rhythm, e.g., that matches the human circadian rhythm of a condition's symptoms and/or of the individual being treated in the application of the therapy to optimize therapeutic outcome and minimize side effects.


Find Patent Forward Citations

Loading…